Designated Filer Sample Clauses

The Designated Filer clause identifies the specific party responsible for submitting required filings or documents to regulatory authorities or other relevant entities. In practice, this clause clarifies which party—such as a lead investor, company representative, or legal counsel—must prepare and file documents like tax forms, compliance reports, or transaction notifications. By clearly assigning this responsibility, the clause helps prevent confusion or missed deadlines, ensuring that all necessary filings are completed in a timely and organized manner.
Designated Filer. 2056A–10 Surviving spouse becomes citizen after QDOT established.
Designated Filer. On September 19, 2008, the Commission issued its e-Tariff Final rule, which requires public utilities to file all tariffs and tariff revisions electronically beginning on April 1, 2010. The e- Tariff Final Rule directs, inter alia, that when multiple utilities are party to the same tariff (a “joint tariff”), the parties may designate one utility as the designated filer of the baseline tariff filing.7 The non-designated utility is required to submit as its baseline filing a tariff section that provides the appropriate name of the tariff and identifies the utility that is designated filing for the joint tariff. Under the Commission’s e-tariff filing rules, entities desiring to submit e-tariff filings first must register on the Commission’s website to obtain a Company Identifier (one of the required data elements to enter the Commission’s e-tariff filing web page and submit an e-tariff filing). However, “Northern States Power Companies” (or “NSP Companies”) is not an entity that is qualified to register for a Company ID under the Commission’s rules, and as such may not submit e-tariff filings. Therefore, the NSP Companies have chosen NSPM as the party that will submit the Interchange Agreement. NSPW is submitting a tariff record that will identify the Interchange Agreement filed by NSPM as a tariff to which NSPW is a party.

Related to Designated Filer

  • Designated Prescription Drug Prescribers and Pharmacies We may limit your selection of a pharmacy to a single pharmacy location and/or a single prescribing provider or practice. Those members subject to this designation include, but are not limited to, members that have a history of: • being prescribed prescription drugs by multiple providers; • having prescriptions drugs filled at multiple pharmacies; • being prescribed certain long-acting opioids and other controlled substances, either in combination or separately, that suggests a need for monitoring due to: o quantities dispensed; o daily dosage range; or o the duration of therapy exceeds reasonable and established thresholds.

  • How to File an Appeal of a Prescription Drug Denial For denials of a prescription drug claim based on our determination that the service was not medically necessary or appropriate, or that the service was experimental or investigational, you may request an appeal without first submitting a request for reconsideration. You or your physician may file a written or verbal prescription drug appeal with our pharmacy benefits manager (PBM). The prescription drug appeal must be submitted to us within one hundred and eighty (180) calendar days of the initial determination letter. You will receive written notification of our determination within thirty (30) calendar days from the receipt of your appeal. Your appeal may require immediate action if a delay in treatment could seriously jeopardize your health or your ability to regain maximum function, or would cause you severe pain. To request an expedited appeal of a denial related to services that have not yet been rendered (a preauthorization review) or for on-going services (a concurrent review), you or your healthcare provider should call: • our Grievance and Appeals Unit; or • our pharmacy benefits manager for a prescription drug appeal. Please see Section 9 for contact information. You will be notified of our decision no later than seventy-two (72) hours after our receipt of the request. You may not request an expedited review of covered healthcare services already received.

  • PRODUCTS MANUFACTURED IN PUBLIC INSTITUTIONS Bids offering Products that are manufactured or produced in public institutions will be rejected.

  • LEAST RESTRICTIVE ENVIRONMENT/DUAL ENROLLMENT CONTRACTOR and ▇▇▇ shall follow all LEA policies and procedures that support Least Restrictive Environment (“LRE”) options and/or dual enrollment options if available and appropriate, for students to have access to the general curriculum and to be educated with their nondisabled peers to the maximum extent appropriate. CONTRACTOR and ▇▇▇ shall ensure that LRE placement options are addressed at all IEP team meetings regarding students for whom ISAs have been or may be executed. This shall include IEP team consideration of supplementary aids and services, goals and objectives necessary for placement in the LRE and necessary to enable students to transition to less restrictive settings. When an IEP team has determined that a student should be transitioned into the public school setting, CONTRACTOR shall assist the LEA in implementing the IEP team’s recommended activities to support the transition.

  • Wire Transfer Eligibility Section 11.24